View 3 Images

Patients are being warned of ongoing disruption to supplies of a commonly prescribed ADHD medicines, after the Government confirmed one medication will remain out of stock for weeks.

Health minister Dr Zubir Ahmed has responded to concerns over the supply and availability of attention deficit hyperactivity disorder (ADHD) medication.

He said "substantial progress" has been made in tackling widespread shortages of ADHD medicines seen earlier this year, with most products now back on shelves.

These include all strengths of lisdexamfetamine, both capsules and oral solution of atomoxetine, guanfacine prolonged-release tablets, and several forms of methylphenidate.

However, one key treatment - methylphenidate 30mg prolonged-release capsules, sold under the brand name Equa

See Full Page